Can Adenosine 5′-Triphosphate Be Used to Select Treatment in Severe Vasovagal Syndrome?
Authors:
- 19 August 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 96 (4) , 1201-1208
Abstract
BackgroundSelection of treatment in vasovagal syndrome should be guided by the mechanism of symptoms. This study determined whether a simple drug test may assess one mechanism.Methods and ResultsTo identify patients at risk of severe cardioinhibitory response of vagal origin, we infused 20 mg ATP into 316 patients hospitalized for recurrent syncope (n=195) or presyncope (n=121) of unknown origin and into normal subjects (n=51). We then assessed the ECG and clinical responses to the drug, recommended therapy, and followed up the subjects chronically. A cardiac pause >10 seconds was seen in only 3 normal subjects (6%). Therefore, a pause ≤10 seconds yielded the ≈95th percentile of the normal range. ATP provoked a pause >10 seconds in 130 symptomatic patients (41%) and a pause ≤10 seconds in 186 symptomatic patients (59%). Thus, symptomatic patients with pauses >10 seconds were proposed for pacemaker implantation; all other patients and normal subjects were simply monitored. Among long-pause patients with follow-up, the observed recurrence rate for the 104 with pacemakers was one-third that for the 21 who were only monitored (P<.0001). Among followed-up short-pause patients, the rate in the 153 monitored-only patients did not differ from the 20 implanted patients (P=.432).ConclusionsThe vagal effect of ATP may identify the subgroup of patients at high risk of severe cardioinhibitory response of vagal origin who likely will benefit from pacemaker therapy. This fast, uncomplicated test should be considered for further use in screening patients with vasovagal syndrome.Keywords
This publication has 26 references indexed in Scilit:
- The Clinical Spectrum of Neurocardiogenic SyncopeJournal of Cardiovascular Electrophysiology, 1995
- Neurocardiogenic SyncopeNew England Journal of Medicine, 1993
- Reproducibility of Head Upright Tilt Table Test Results in Patients with SyncopePacing and Clinical Electrophysiology, 1992
- Evaluation of Syncope by Upright Tilt Testing with IsoproterenolAnnals of Internal Medicine, 1992
- What exactly is 2+ to 3+ mitral regurgitation?JACC, 1992
- Methodology of head-up tilt testing in patients with unexplained syncopeJACC, 1991
- Diagnosis and natural history of syncope and the role of invasive electrophysiologic testingThe American Journal of Cardiology, 1989
- Provocation of Bradycardia and Hypotension by Isoproterenol and Upright Posture in Patients with Unexplained SyncopeNew England Journal of Medicine, 1989
- Malignant vasovagal syncope: prolonged asystole provoked by head-up tilt: Case report and review of diagnosis, pathophysiology, and therapyCleveland Clinic Journal of Medicine, 1988
- The Usefulness of Head‐Up Tilt Testing and Hemodynamic Investigations in the Workup of Syncope of Unknown OriginPacing and Clinical Electrophysiology, 1988